JP2016193934A5 - - Google Patents

Download PDF

Info

Publication number
JP2016193934A5
JP2016193934A5 JP2016137224A JP2016137224A JP2016193934A5 JP 2016193934 A5 JP2016193934 A5 JP 2016193934A5 JP 2016137224 A JP2016137224 A JP 2016137224A JP 2016137224 A JP2016137224 A JP 2016137224A JP 2016193934 A5 JP2016193934 A5 JP 2016193934A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
independently
group
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016137224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016193934A (ja
JP6368745B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016193934A publication Critical patent/JP2016193934A/ja
Publication of JP2016193934A5 publication Critical patent/JP2016193934A5/ja
Application granted granted Critical
Publication of JP6368745B2 publication Critical patent/JP6368745B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016137224A 2010-10-14 2016-07-12 プレターゲットキット、プレターゲット方法及びその使用試薬 Active JP6368745B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10187619.1 2010-10-14
EP10187619 2010-10-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013533311A Division JP6063384B2 (ja) 2010-10-14 2011-10-11 プレターゲットキット、プレターゲット方法及びその使用試薬

Publications (3)

Publication Number Publication Date
JP2016193934A JP2016193934A (ja) 2016-11-17
JP2016193934A5 true JP2016193934A5 (enExample) 2017-03-30
JP6368745B2 JP6368745B2 (ja) 2018-08-01

Family

ID=43736149

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013533311A Active JP6063384B2 (ja) 2010-10-14 2011-10-11 プレターゲットキット、プレターゲット方法及びその使用試薬
JP2016137224A Active JP6368745B2 (ja) 2010-10-14 2016-07-12 プレターゲットキット、プレターゲット方法及びその使用試薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013533311A Active JP6063384B2 (ja) 2010-10-14 2011-10-11 プレターゲットキット、プレターゲット方法及びその使用試薬

Country Status (5)

Country Link
US (1) US9463256B2 (enExample)
EP (1) EP2627358B1 (enExample)
JP (2) JP6063384B2 (enExample)
RU (1) RU2013121799A (enExample)
WO (1) WO2012049624A1 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9463256B2 (en) * 2010-10-14 2016-10-11 Koninklijke Philips N.V. Pretargeting kit, method and agents used therein
EP2522369A1 (en) 2011-05-09 2012-11-14 Koninklijke Philips Electronics N.V. Pretargeting kit, method and agents used therein
JP6482273B2 (ja) * 2011-05-16 2019-03-13 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. 生体直交型薬物活性化
JP2015518722A (ja) * 2012-05-21 2015-07-06 アジレント・テクノロジーズ・インクAgilent Technologies, Inc. Dna/rna用途における切断可能なリンカーとしてのレトロディールスアルダー反応
FI2922574T3 (fi) * 2012-11-22 2023-08-11 Tagworks Pharmaceuticals B V Kemiallisesti pilkkoutuva ryhmä
WO2014081299A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Activatable liposomes
WO2014081300A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Channel protein activatable liposomes
WO2014081301A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Bio-orthogonal drug activation
EP2948186A4 (en) * 2013-01-25 2016-10-05 Sloan Kettering Inst Cancer TETRAZINE / TRANSCYCLOOKTENE IN SOLID PHASE SYNTHESIS MARKED PEPTIDE
US9110230B2 (en) 2013-05-07 2015-08-18 Corning Incorporated Scratch-resistant articles with retained optical properties
US9366784B2 (en) 2013-05-07 2016-06-14 Corning Incorporated Low-color scratch-resistant articles with a multilayer optical film
ES2966631T3 (es) 2013-06-19 2024-04-23 Univ California Estructuras químicas para el suministro localizado de agentes terapéuticos
WO2015103484A1 (en) 2014-01-04 2015-07-09 Vijay Agarwal Device and method for use of photodynamic therapy
US20160346409A1 (en) * 2014-02-10 2016-12-01 Mcmaster University Targeted molecular imaging contrast agents
CN106659796B (zh) 2014-03-14 2021-04-30 加利福尼亚大学董事会 Tco缀合物和治疗剂递送方法
WO2015154082A1 (en) * 2014-04-04 2015-10-08 President And Fellows Of Harvard College Refillable drug delivery devices and methods of use thereof
US11267973B2 (en) 2014-05-12 2022-03-08 Corning Incorporated Durable anti-reflective articles
US9790593B2 (en) 2014-08-01 2017-10-17 Corning Incorporated Scratch-resistant materials and articles including the same
US10179775B2 (en) 2014-08-11 2019-01-15 The General Hospital Corporation Cyclooctenes for bioorthogonol reactions
WO2017044983A1 (en) 2015-09-10 2017-03-16 Shasqi, Inc. Bioorthogonal compositions
CN112213802A (zh) 2015-09-14 2021-01-12 康宁股份有限公司 减反射制品以及包含其的显示器装置
EP3153155B1 (en) * 2015-10-08 2021-03-03 President and Fellows of Harvard College Refillable drug delivery devices and methods of use thereof
WO2018004338A1 (en) 2016-06-27 2018-01-04 Tagworks Pharmaceuticals B.V. Cleavable tetrazine used in bio-orthogonal drug activation
EP3606559B1 (en) 2017-04-07 2024-06-05 Tambo, Inc. Bioorthogonal compositions
US11560384B2 (en) 2017-05-04 2023-01-24 University Of Utah Research Foundation Benzonorbornadiene derivatives and reactions thereof
CN110891614A (zh) * 2017-05-05 2020-03-17 融合制药公司 Igf-1r单克隆抗体及其用途
EP3651741A4 (en) 2017-07-14 2021-04-21 The Penn State Research Foundation Compositions and methods for targeted delivery of therapeutic and/or diagnostic species
GB201720769D0 (en) 2017-12-13 2018-01-24 Univ Of Northumbria At Newcastle Pericyclic reactions
EA202091420A1 (ru) 2017-12-18 2020-09-10 Янссен Байотек, Инк. Радиоактивное мечение полипептидов
AU2019262521B2 (en) 2018-05-04 2024-04-18 Tagworks Pharmaceuticals B.V. Compounds comprising a linker for increasing transcyclooctene stability
CA3099419A1 (en) 2018-05-04 2019-11-07 Tagworks Pharmaceuticals B.V. Tetrazines for high click conjugation yield in vivo and high click release yield
KR102591065B1 (ko) 2018-08-17 2023-10-19 코닝 인코포레이티드 얇고, 내구성 있는 반사-방지 구조를 갖는 무기산화물 물품
WO2020061103A1 (en) 2018-09-18 2020-03-26 Nikang Therapeutics, Inc. Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
AU2020221841B2 (en) 2019-02-13 2025-10-09 Alpheus Medical, Inc. Non-invasive sonodynamic therapy
BR112021023836A8 (pt) 2019-05-29 2023-02-28 Sonalasense Inc Sonossensibilização
IL289095A (en) 2019-06-17 2022-02-01 Tagworks Pharmaceuticals B V Activating components to cleave labels from biomolecules in vivo
US12147009B2 (en) 2020-07-09 2024-11-19 Corning Incorporated Textured region to reduce specular reflectance including a low refractive index substrate with higher elevated surfaces and lower elevated surfaces and a high refractive index material disposed on the lower elevated surfaces
CA3185803A1 (en) 2020-08-07 2022-02-10 Vijay Agarwal Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
EP4108669A1 (en) * 2021-06-24 2022-12-28 Institute Of Organic Chemistry And Biochemistry As CR, V.V.I. Carbohydrate derivatives and kits for cell surface labeling
WO2025059685A1 (en) * 2023-09-15 2025-03-20 Tambo, Inc. Methods for in vivo targeted delivery of a payload

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US5326856A (en) 1992-04-09 1994-07-05 Cytogen Corporation Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
WO2007039858A2 (en) * 2005-10-04 2007-04-12 Koninklijke Philips Electronics N.V. Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition
EP3622968A1 (en) 2008-10-31 2020-03-18 The General Hospital Corporation Compositions and methods for delivering a substance to a biological target
BRPI1006246A2 (pt) * 2009-04-16 2020-02-04 Koninl Philips Electronics Nv "kit para imagem médica marcada e/ou terapias, sonda efetora e método"
US9463256B2 (en) * 2010-10-14 2016-10-11 Koninklijke Philips N.V. Pretargeting kit, method and agents used therein
FI2922574T3 (fi) * 2012-11-22 2023-08-11 Tagworks Pharmaceuticals B V Kemiallisesti pilkkoutuva ryhmä

Similar Documents

Publication Publication Date Title
JP2016193934A5 (enExample)
RU2013121799A (ru) Набор для претаргетинга, способ и агенты, применяемые в нем
JP2014518861A5 (enExample)
EP4473980A3 (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers
RU2118325C1 (ru) Комплексы металлов с бициклополиазамакроциклом, способ их получения и фармацевтическая композиция для лечения рака
KR101931382B1 (ko) 토륨 방사성 핵종 및 히드록시피리디논 함유 리간드를 포함하는 표적화된 알파-입자 방출 복합체
TWI384989B (zh) 氨基磷酸化物烷化劑前藥
US10280183B2 (en) Therapeutic agent for treating tumors
JP2012511023A5 (enExample)
JP2012530713A5 (enExample)
JP2017528467A5 (enExample)
JPH02504269A (ja) アミノポリカルボン酸およびその誘導体
UA76726C2 (uk) Метаботропічні антагоністи рецептора глутамату, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб її одержання
JP2011526917A5 (enExample)
JP2008533191A5 (enExample)
JP5960253B2 (ja) ポリ(adp−リボース)ポリメラーゼの三環系阻害剤
JP2012522759A5 (enExample)
JP2012520271A5 (enExample)
KR20110013411A (ko) (f-19)-표지된 l-글루탐산 및 l-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법
WO2008043911A3 (fr) Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant
JP2020506244A5 (enExample)
JP2020506970A5 (enExample)
US9173946B2 (en) Bifunctional hydroxy-bisphosphonic acid derivatives
JP2010516762A (ja) ポリマー結合ビスホスホネート吸入剤及びその使用方法
AU2017283653B2 (en) Porphyrin compounds and compositions useful for treating cancer